Why are some antiarrhythmic drugs proarrhythmic? Cardiac arrhythmia study by bifurcation analysis

T R Chay1

  • 1Department of Biological Sciences, University of Pittsburgh, PA 15260, USA.

Insights

This study reveals how ion channels influence cardiac arrhythmias. Potassium channel blockers effectively control reentry, while sodium and calcium channel blockers can worsen arrhythmias by altering the critical ring size.

Area of Science:

  • Computational biology
  • Cardiac electrophysiology
  • Pharmacology

Background:

  • Cardiac arrhythmias are a major cause of mortality.
  • Understanding the role of ion channels in cardiac electrophysiology is crucial for developing effective antiarrhythmic therapies.

Purpose of the Study:

  • To elucidate the effect of key ion channels on cardiac arrhythmias using bifurcation analysis.
  • To explain the efficacy of antiarrhythmic drugs in controlling arrhythmias.
  • To investigate the impact of ion channel blockers on critical ring size and reentry dynamics.

Main Methods:

  • Bifurcation analysis of a cardiac tissue model.
  • Modeling ventricular action potential with fast sodium, slow calcium, and background potassium channels.
  • Simulating a ring structure to analyze reentrant arrhythmias.

Main Results:

  • A critical ring size (CRS) was identified, influencing action potential amplitude and conduction velocity (CV) stability.
  • Sodium channel blockers decrease CRS, promoting reentry (proarrhythmia).
  • Calcium channel blockers shorten CRS, also exerting a proarrhythmic effect.
  • Potassium channel blockers lengthen CRS, controlling reentry, but near-complete blockade can cause ectopic foci.

Conclusions:

  • Key ion channels significantly affect cardiac reentry dynamics and critical loop length.
  • The study provides a theoretical basis for the proarrhythmic effects of certain antiarrhythmic drugs.
  • Bifurcation analysis offers insights into drug-induced arrhythmias and guides therapeutic strategies.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...